(Q64868728)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

Gene co-expression network analysis for identifying genetic markers in Parkinson's disease - a three-way comparative approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Gincy George

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Sowmya Bekshe Lokappa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jobin Varkey

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

28 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

819-830

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

Molecular pathophysiology of Parkinson's disease

29 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

α-Synuclein in Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Genetics of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Genetics and genomics of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Remodeling of lipid vesicles into cylindrical micelles by α-synuclein in an extended α-helical conformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

α-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

alpha-Synuclein locus triplication causes Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Clinical implications of Parkinson's disease genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Network medicine: a network-based approach to human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Why do hubs tend to be essential in protein networks?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

KEGG: kyoto encyclopedia of genes and genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

DJ-1 binds to mitochondrial complex I and maintains its activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

GOstat: find statistically overrepresented Gene Ontologies within a group of genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

A new measure for functional similarity of gene products based on Gene Ontology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Cytoscape: a software environment for integrated models of biomolecular interaction networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

BisoGenet: a new tool for gene network building, visualization and analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Computing topological parameters of biological networks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

A computational framework for the prioritization of disease-gene candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

WebGestalt: an integrated system for exploring gene sets in various biological contexts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

ToppGene Suite for gene list enrichment analysis and candidate gene prioritization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

An algorithm for modularity analysis of directed and weighted biological networks based on edge-betweenness centrality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Topological properties of protein interaction networks from a structural perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

High-betweenness proteins in the yeast protein interaction network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Role of the ubiquitin proteasome system in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Programmed cell death in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Differential network biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Human diseases through the lens of network biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

A network approach to clinical intervention in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

A computational analysis of protein-protein interaction networks in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Discovering the 3' UTR-mediated regulation of alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

The parkin protein as a therapeutic target in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Can parkin be a target for future treatment of Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Sustained translational repression by eIF2α-P mediates prion neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Heat shock proteins in neurodegenerative disorders and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

The translation elongation factor eEF1A1 couples transcription to translation during heat shock response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Interactions with PDZ proteins are required for L-type calcium channels to activate cAMP response element-binding protein-dependent gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2018.05.005

10.1016/J.YGENO.2018.05.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29852216%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference